Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
about
Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Elevated Spontaneous Interferon-γ Secretion in Human Immunodeficiency Virus-Infected PersonsAn expanding role for interleukin-1 blockade from gout to cancer.Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.Hyperferritinemic Sepsis: An Opportunity for Earlier Diagnosis and Intervention?Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based ReviewIsoniazid Induced Lupus Presenting as Oral Mucosal Ulcers with Pancytopenia.Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.Treatment of adult-onset still's disease: up to date.An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.Immunotherapeutic implications of IL-6 blockade for cytokine storm.The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome.The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still's Disease.Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient.Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis.Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil.Broadleaf Mahonia attenuates granulomatous lobular mastitis‑associated inflammation by inhibiting CCL‑5 expression in macrophages.Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review.Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms.Macrophages and the Recovery from Acute and Chronic Inflammation.Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome.Precision Immunotherapy for SepsisModulation of Iron Metabolism in Response to Infection: Twists for All TastesMacrophage activation syndrome: early diagnosis is keyAnakinra Therapy for Non-cancer Inflammatory Diseases
P2860
Q33439759-7B70E48B-5B04-4698-9D6A-77506BB51497Q33772397-508C08FF-0C89-45EC-872F-C71B06FFDF2FQ35219001-21D4EDD5-47B7-496A-A326-C2179F2B03ECQ36052006-DED0B81C-5EC3-4BF4-B742-22683B8FF842Q36435134-BABEAED0-AD1B-474D-9845-57D7CA6E0E29Q36654557-6F78C3F8-476C-49B2-ACE8-578481FAF42AQ37143658-E283BD47-0717-48B4-8410-77C1B204FAB7Q37263772-7A52703A-577E-47AD-8205-32F562D526E4Q37435557-23F7514B-9E7E-4984-B8CB-537BB451E57DQ37735696-CE8AEE3B-9A93-4384-B088-CE7AAF01EE62Q38679486-2DA0B1A8-54B8-4096-B83B-77CC1EF8DC49Q38830731-C62CF094-A92D-47F1-9CDE-1E0FA3F794D7Q38887311-50FF4FBE-CC75-4F2C-BC6F-F53DC4ABC9C6Q40082328-543A8FC4-FCE7-4000-B1AE-3B45DDFBD8D6Q40116584-F663CC2C-5B52-4D4B-BCF1-257387C50D75Q40395354-E6786445-DDE2-4E84-82E5-F191432C2D6DQ41029387-0668D7ED-E6E5-4AA2-A419-207118C5DEAEQ41835917-91A1052B-9294-406D-82B1-536A34153F46Q42322137-DEEE8BD7-14EE-4A17-BB67-7228ADCB251DQ43373049-5DEB5A83-6D8F-4CEB-8416-87BBFFE7BF66Q46261261-7A200D3D-2E32-4CD8-9ED7-B2667070F805Q47235167-3C5F823E-AFA4-4B78-8FC9-AAE7974770CCQ47547112-596C60EA-3E4F-4841-A9A1-C7784205554EQ47651267-165A8F82-7035-485A-A05A-192F3F31B349Q47931407-B59D2712-B892-4193-AF39-348D457754A8Q49251571-6579CED0-AC49-408F-8176-50062D0DEAC2Q49942692-42F6A96E-8E88-4161-A689-CBE57A5C59E5Q49977551-EA9FDBE6-D9C2-4290-BAE6-35B0BCDBFBF6Q51270292-7D7D016F-1960-4AC6-B867-0F647FF7A8BBQ54253814-EB6D9FC3-7364-4FC3-A086-A12E2B2409F3Q57160595-C21A8A95-EF2F-4288-BCC1-6164167F4C62Q57617763-E5B2C205-4338-4F09-B0A8-B640DEEF28C0Q58781634-6031818C-8837-4927-AEC5-A3B12E0B0539Q59136398-68E4E2C6-EC8C-4EE8-9F41-6B31031ED4BE
P2860
Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pathogenesis of macrophage act ...... cytokine- directed therapies.
@en
type
label
Pathogenesis of macrophage act ...... cytokine- directed therapies.
@en
prefLabel
Pathogenesis of macrophage act ...... cytokine- directed therapies.
@en
P2860
P1476
Pathogenesis of macrophage act ...... cytokine- directed therapies.
@en
P2093
Alexei A Grom
Grant S Schulert
P2860
P304
P356
10.1146/ANNUREV-MED-061813-012806
P577
2014-11-05T00:00:00Z